ResearcherGautam Buddha UniversityActive in the last 2 years
Shakti Sahi
Matched on ORCID iD 0000-0002-9931-7993; OpenAlex author ID A5086787416. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 2
2024: 2 papers · 2025: none · 2026: 1 paper
Papers 3
- Unveiling therapeutic potential: In Silico discovery of prognostic markers and potential inhibitors for TGFßR1 in pancreatic cancer. Last author DOI 10.1016/j.compbiolchem.2025.108646↗
- AI screening and molecular dynamic simulation-driven identification of novel inhibitors of TGFßR1 for pancreatic cancer therapy. Last author DOI 10.1016/j.compbiolchem.2024.108262↗
- Identification of Prognostic Markers and Potential Therapeutic Targets using Gene Expression Profiling and Simulation Studies in Pancreatic Cancer. Last author DOI 10.2174/1573409920666230914100826↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Samvedna Singh · 3 shared papers, 2024–2026 · strength 0.87
- Paper Unveiling therapeutic potential: In Silico discovery of prognostic markers and potential inhibitors for TGFßR1 in pancr… DOI 10.1016/j.compbiolchem.2025.108646↗
- Paper AI screening and molecular dynamic simulation-driven identification of novel inhibitors of TGFßR1 for pancreatic cancer… DOI 10.1016/j.compbiolchem.2024.108262↗
- Paper Identification of Prognostic Markers and Potential Therapeutic Targets using Gene Expression Profiling and Simulation S… DOI 10.2174/1573409920666230914100826↗
- Aman Chandra Kaushik · 3 shared papers, 2024–2026 · strength 0.87
- Paper Unveiling therapeutic potential: In Silico discovery of prognostic markers and potential inhibitors for TGFßR1 in pancr… DOI 10.1016/j.compbiolchem.2025.108646↗
- Paper AI screening and molecular dynamic simulation-driven identification of novel inhibitors of TGFßR1 for pancreatic cancer… DOI 10.1016/j.compbiolchem.2024.108262↗
- Paper Identification of Prognostic Markers and Potential Therapeutic Targets using Gene Expression Profiling and Simulation S… DOI 10.2174/1573409920666230914100826↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.